Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015

Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015

Background: Recent studies in several countries show a significant decrease in the consumption of osteoporosis drugs from a peak around 2009, mainly attributed to bisphosphonate safety warnings issued by regulatory agencies on jaw osteonecrosis, atypical fractures, and esophageal cancer, but no stud...

Full description

Bibliographic Details
Main Authors: Isabel Hurtado-Navarro, Aníbal García-Sempere, Clara Rodríguez-Bernal, José Sanfélix-Genovés, Salvador Peiró, Gabriel Sanfélix-Gimeno
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Pharmacology
Subjects:
osteoporosis
bisphosphonates
drug labeling
cost-sharing
appropriateness
utilization
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00768/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00768/full

Similar Items